Aktuellt
SENASTE
Redeye provides a brief take on Integrum’s Q3 report, and we note a -20% deviation from our sales estimates, resulting in a miss on our operating results forecast. While relatively disappointing (especially for the short-term shareholder), we highlight the early stage Integrum is in and see the company continue delivering well on its fundamental commercial groundwork.
LÄS MER
